CIK 0001661998 · Non-accelerated filer<br>Smaller reporting company
Q32 Bio Inc.
Sign in to watch- Ticker
- QTTB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473468154
- Phone
- 781-999-0232
- Business address
- 830 WINTER STREET, WALTHAM, MA, 02451
- Former names
- Q32 Bio Inc., Homology Medicines, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $320,396
- in 6 filings
Net −$320,396. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-25 | TZIANABOS ARTHUR Director | Sale | −265 | $24.20 | $6K | 7,983 |
| 2024-03-25 | TZIANABOS ARTHUR Director | Option exercise · Restricted Stock Units | −1,095 | 0 | ||
| 2024-03-25 | Alloway Paul See Remarks | Sale | −268 | $24.21 | $6K | 2,596 |
| 2024-03-25 | Michaud Charles Jr See Remarks | Sale | −75 | $24.20 | $2K | 927 |
| 2024-03-25 | TZIANABOS ARTHUR Director | Grant or award · Stock Option (Right to Buy) | +12,767 | 12,767 | ||
| 2024-03-25 | Manke Isaac Director | Grant or award · Stock Option (Right to Buy) | +12,767 | 12,767 | ||
| 2024-03-25 | Iwicki Mark T Director | Grant or award · Stock Option (Right to Buy) | +25,534 | 25,534 | ||
| 2024-03-25 | GRAYZEL DAVID S. Director | Grant or award · Stock Option (Right to Buy) | +12,767 | 12,767 | ||
| 2024-03-25 | Xu Diyong Director | Grant or award · Stock Option (Right to Buy) | +12,767 | 12,767 | ||
| 2024-03-25 | Campagna Jason Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +70,687 | 70,687 | ||
| 2024-03-25 | Morrison Jodie Pope CEO | Grant or award · Stock Option (Right to Buy) | +394,445 | 394,445 | ||
| 2024-03-25 | Violette Shelia M. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +56,413 | 56,413 | ||
| 2024-03-25 | LAPORTE KATHLEEN Director | Grant or award · Stock Option (Right to Buy) | +12,767 | 12,767 | ||
| 2024-03-25 | Kalowski Lee CFO and President | Grant or award · Stock Option (Right to Buy) | +161,323 | 161,323 | ||
| 2024-03-25 | Thistle Mary Director | Grant or award · Stock Option (Right to Buy) | +12,767 | 12,767 | ||
| 2024-03-25 | Lundberg Sven Ante Director | Grant or award · Stock Option (Right to Buy) | +12,767 | 12,767 | ||
| 2024-03-25 | Alloway Paul See Remarks | Option exercise | +23,530 | 51,566 | ||
| 2024-03-25 | Alloway Paul See Remarks | Option exercise · Restricted Stock Units | −5,440 | 0 | ||
| 2024-03-25 | Alloway Paul See Remarks | Option exercise · Restricted Stock Units | −18,090 | 0 | ||
| 2024-03-25 | Michaud Charles Jr See Remarks | Option exercise | +6,448 | 18,046 |
Page 8 of 11 · 207 trades